22 related articles for article (PubMed ID: 38302173)
1. Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test.
Di Matteo A; Mankia K; Garcia-Montoya L; Sharrack S; Duquenne L; Nam JL; Mahler M; Emery P
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599655
[TBL] [Abstract][Full Text] [Related]
2. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data.
Lee H; Sparks JA; Lee SB; Yoshida K; Landon JE; Kim SC
Pharmacoepidemiol Drug Saf; 2023 May; 32(5):586-591. PubMed ID: 36728737
[TBL] [Abstract][Full Text] [Related]
3. The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19.
Roghani SA; Dastbaz M; Lotfi R; Shamsi A; Abdan Z; Rostampour R; Soleymani B; Zamanian MH; Soufivand P; Pournazari M; Taghadosi M
Immun Inflamm Dis; 2024 May; 12(5):e1276. PubMed ID: 38780036
[TBL] [Abstract][Full Text] [Related]
4. Anti-CCP biosensors in rheumatoid arthritis.
Karami P; Gholamin D; Fathi F; Afsar T; Johari-Ahar M
Clin Chim Acta; 2024 Jun; 561():119767. PubMed ID: 38857671
[TBL] [Abstract][Full Text] [Related]
5. The Kaleidoscope of Polyautoimmunity: An Odyssey of Diagnostic Dilemmas.
Tripathi P; Bhushan D; Banerjee A; Mahto M
Cureus; 2024 Apr; 16(4):e57799. PubMed ID: 38721186
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of ichthyoses in Denmark - a nationwide registry-based study.
Thein D; Maul JT; Schmid-Grendelmeier P; Thyssen JP; Egeberg A
Br J Dermatol; 2024 May; ():. PubMed ID: 38693762
[No Abstract] [Full Text] [Related]
7. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
Hayashi N; Kumagai S
Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
[TBL] [Abstract][Full Text] [Related]
9. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.
Ford JA; Liu X; Marshall AA; Zaccardelli A; Prado MG; Wiyarand C; Lu B; Karlson EW; Schur PH; Deane KD; Sparks JA
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1583-1592. PubMed ID: 30570827
[TBL] [Abstract][Full Text] [Related]
10. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
11. Effects of Aging on Rheumatoid Factor and Anticyclic Citrullinated Peptide Antibody Positivity in Patients With Rheumatoid Arthritis.
Takanashi S; Takeuchi T; Kaneko Y
J Rheumatol; 2023 Mar; 50(3):330-334. PubMed ID: 36319009
[TBL] [Abstract][Full Text] [Related]
12. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
13. Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark.
Kristensen S; Hagelskjær AM; Cordtz R; Bliddal S; Mortensen AS; Nielsen CH; Feldt-Rasmussen U; Lauridsen KB; Dreyer L
J Rheumatol; 2024 Apr; 51(4):350-359. PubMed ID: 38302173
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
